Neith Corporation (6236.TWO)
- Previous Close
27.80 - Open
27.60 - Bid --
- Ask 30.00 x --
- Day's Range
27.60 - 27.80 - 52 Week Range
23.90 - 37.15 - Volume
6,000 - Avg. Volume
704 - Market Cap (intraday)
1.158B - Beta (5Y Monthly) 0.11
- PE Ratio (TTM)
-- - EPS (TTM)
-0.07 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Neith Corporation engages in the biotechnology, medical cosmetics, and preventive medicine businesses. The company offers nutritional products, including L-One, a liquid formula for maintaining eye health; EPlus, a multiple enzyme supplement; and other nutritional products under the King One name. It also provides genetic testing services. In addition, the company offers energy and dual-purpose mattresses, energy masks, energy silicon gel necklaces, energy waistbands, energy heating stones, massage rods, and water purifiers, as well as Ganbanyoku, an energy stone spa bed. Further, it provides beauty care products, such as cell regeneration and rejuvenation series skin care products; home energy products; and microcontrollers and peripherals. The company was formerly known as Come True Biomedical Inc. Neith Corporation was incorporated in 1997 and is headquartered in Taichung, Taiwan.
www.neithcorp.comRecent News: 6236.TWO
View MorePerformance Overview: 6236.TWO
Trailing total returns as of 5/29/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 6236.TWO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 6236.TWO
View MoreValuation Measures
Market Cap
1.16B
Enterprise Value
1.03B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
23.71
Price/Book (mrq)
7.40
Enterprise Value/Revenue
21.35
Enterprise Value/EBITDA
578.77
Financial Highlights
Profitability and Income Statement
Profit Margin
-6.02%
Return on Assets (ttm)
-3.70%
Return on Equity (ttm)
-1.81%
Revenue (ttm)
48.28M
Net Income Avi to Common (ttm)
-2.91M
Diluted EPS (ttm)
-0.07
Balance Sheet and Cash Flow
Total Cash (mrq)
136.4M
Total Debt/Equity (mrq)
5.88%
Levered Free Cash Flow (ttm)
-9.16M